Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol

Giuseppe Malleo, Laura Maggino, Fabio Casciani, Gabriella Lionetto, Sara Nobile, Gianni Lazzarin, Salvatore Paiella, Alessandro Esposito, Paola Capelli, Claudio Luchini, Aldo Scarpa, Claudio Bassi, Roberto Salvia, Giuseppe Malleo, Laura Maggino, Fabio Casciani, Gabriella Lionetto, Sara Nobile, Gianni Lazzarin, Salvatore Paiella, Alessandro Esposito, Paola Capelli, Claudio Luchini, Aldo Scarpa, Claudio Bassi, Roberto Salvia

Abstract

Background: Implementing a prospective lymphadenectomy protocol, we investigated the nodal yields and metastases per anatomical stations and nodal echelon following upfront pancreatoduodenectomy (PD) for cancer. Next, the relationship between the extension of nodal dissection, the number of examined and positive nodes (ELN/PLN), disease staging and prognosis was assessed.

Methods: Lymphadenectomy included stations 5, 6, 8a-p, 12a-b-p, 13, 14a-b, 17, and jejunal mesentery nodes. Data were stratified by N-status, anatomical stations, and nodal echelons. First echelon was defined as stations embedded in the main specimen and second echelon as stations sampled as separate specimens. Recurrence and survival analyses were performed by using standard statistics.

Results: Overall, 424 patients were enrolled from June 2013 through December 2018. The median number of ELN and PLN was 42 (interquartile range [IQR] 34-50) and 4 (IQR 2-8). Node-positive patients were 88.2%. The commonest metastatic sites were stations 13 (77.8%) and 14 (57.5%). The median number of ELN and PLN in the first echelon was 28 (IQR 23-34) and 4 (IQR 1-7). While first-echelon dissection provided enough ELN for optimal nodal staging, the aggregate rate of second-echelon metastases approached 30%. Nodal-related factors associated with recurrence and survival were N-status, multiple metastatic stations, metastases to station 14, and jejunal mesentery nodes.

Conclusions: First-echelon dissection provides adequate number of ELN for optimal staging. Nodal metastases occur mostly at stations 13/14, although second-echelon involvement is frequent. Only station 14 and jejunal mesentery nodes involvement was prognostically relevant. This latter station should be included in the standard nodal map and analyzed pathologically.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Institutional nodal dissection (anatomical stations and echelons) during PD for PDAC
Fig. 2
Fig. 2
Kaplan-Meier curves of node-positive patients stratified by N-status (A), number of metastatic stations (B), station 14 (C) and jejunal mesentery node status (D)
Fig. 3
Fig. 3
Recurrence status of node-positive patients stratified by nodal echelon involvement (A), nodal status (B), and number of metastatic stations (C)

References

    1. Strobel O, Hinz U, Gluth A, et al. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg. 2015;261:961–9. doi: 10.1097/SLA.0000000000000814.
    1. Allen PJ, Kuk D, Castillo CF, et al. Multi-institutional validation study of the American Joint Commission on Cancer (8 edn) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg. 2017;265:185–91. doi: 10.1097/SLA.0000000000001763.
    1. Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual. 8. New York: Springer; 2018.
    1. Van Roessel S, Kasumova GG, Verheij J, Najarian RM, Maggino L, De Pastena M, Malleo G, Marchegiani G, Salvia R, Ng SC, De Geus SW. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg. 2018;153(12):e183617
    1. Malleo G, Maggino L, Qadan M, et al. Reassessment of the optimal number of examined lymph nodes in pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2020 doi: 10.1097/SLA.0000000000004552.
    1. Kanda M, Fujii T, Nagai S, et al. Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas. 2011;40:951–5. doi: 10.1097/MPA.0b013e3182148342.
    1. Massucco P, Ribero D, Sgotto E, Mellano A, Muratore A, Capussotti L. Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers. Ann Surg Oncol. 2009;16:3323–32. doi: 10.1245/s10434-009-0672-5.
    1. Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS) Surgery. 2014;156:591–600. doi: 10.1016/j.surg.2014.06.016.
    1. Isaji S, Murata Y, Kishiwada M. New Japanese classification of pancreatic cancer. In: Neoptolemos JP, Urrutia R, Abbruzzese JL, Buchler MW, editors. Pancreatic cancer. 2. New York: Springer; 2018. pp. 1021–37.
    1. Malleo G, Maggino L, Marchegiani G, et al. Pancreatectomy with venous resection for pT3 head adenocarcinoma: perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration. Pancreatology. 2017;17:847–57. doi: 10.1016/j.pan.2017.08.005.
    1. Malleo G, Maggino L, Capelli P, et al. Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer. J Am Coll Surg. 2015;221:367–79. doi: 10.1016/j.jamcollsurg.2015.02.019.
    1. Bunt AM, Hermans J, van de Velde CJ, et al. Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol. 1996;14:2289–94. doi: 10.1200/JCO.1996.14.8.2289.
    1. Herbella FAM, Lourenço LG, Bonini AL, Schlottmann F, Patti MG. Anatomical analysis of gastric lymph nodes in cancer-free individuals. Clin Anat. 2019;32:9–12. doi: 10.1002/ca.23241.
    1. Wagner PK, Ramaswamy A, Rüschoff J, Schmitz-Moormann P, Rothmund M. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg. 1991;78:825–7. doi: 10.1002/bjs.1800780719.
    1. Pawlik TM, Abdalla EK, Barnett CC, et al. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg. 2005;140:584–9. doi: 10.1001/archsurg.140.6.584.
    1. Adsay NV, Basturk O, Altinel D, et al. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol. 2009;22:107–12. doi: 10.1038/modpathol.2008.167.
    1. Chaudhry IH, Campbell F. An audit of pathology lymph node dissection techniques in pylorus preserving Kausch-Whipple pancreatoduodenectomy specimens. J Clin Pathol. 2001;54:758–61. doi: 10.1136/jcp.54.10.758.
    1. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229:613–22. doi: 10.1097/00000658-199905000-00003.
    1. Henne-Bruns D, Vogel I, Lüttges J, Klöppel G, Kremer B. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg. 2000;24:595–601. doi: 10.1007/s002689910089.
    1. Schwarz L, Lupinacci RM, Svrcek M, et al. Para-aortic lymph node sampling in pancreatic head adenocarcinoma. Br J Surg. 2014;101:530–8. doi: 10.1002/bjs.9444.
    1. Pranger BK, Tseng DSJ, Ubels S, et al. How to approach para-aortic lymph node metastases during exploration for suspected periampullary carcinoma: resection or bypass? Ann Surg Oncol. 2020;27:2949–58. doi: 10.1245/s10434-020-08304-0.
    1. Paiella S, Malleo G, Maggino L, Bassi C, Salvia R, Butturini G. Pancreatectomy with para-aortic lymph node dissection for pancreatic head adenocarcinoma: pattern of nodal metastasis spread and analysis of prognostic factors. J Gastrointest Surg. 2015;19:1610–20. doi: 10.1007/s11605-015-2882-4.
    1. O’Morchoe C. Lymphatic system of the pancreas. Microsc Res Tech. 1997;37:456–77. doi: 10.1002/(SICI)1097-0029(19970601)37:5/6<456::AID-JEMT9>;2-B.
    1. Cesmebasi A, Malefant J, Patel SD, et al. The surgical anatomy of the lymphatic system of the pancreas. Clin Anat. 2015;28:527–37. doi: 10.1002/ca.22461.
    1. Pissas A. Anatomoclinical and anatomosurgical essay on the lymphatic circulation of the pancreas. Anat Clin. 1984;6:255–80. doi: 10.1007/BF01654459.
    1. Dillhoff M, Pawlik TM. Role of node dissection in pancreatic tumor resection. Ann Surg Oncol. 2021;28:2374–81. doi: 10.1245/s10434-020-09394-6.
    1. Wang W, He Y, Wu L, et al. Efficacy of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic head adenocarcinoma: an update meta-analysis. Pancreatology. 2019;19:1074–80. doi: 10.1016/j.pan.2019.10.003.
    1. Daamen LA, Groot VP, Besselink MG, et al. Detection, treatment, and survival of pancreatic cancer recurrence in the Netherlands: a nationwide analysis. Ann Surg. 2020 Jul 8
    1. Strobel O, Lorenz P, Hinz U, et al. Actual five-year survival after upfront resection for pancreatic ductal adenocarcinoma: Who beats the odds? Ann Surg. 2020;267:936–45.
    1. Groot VP, Rezaee N, Wu W, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267:936–45. doi: 10.1097/SLA.0000000000002234.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir